Presentations

08:00

A multi-centre study of Belatacept and Sirolimus for human islet transplantation

Natasha Rogers (AU)

Bio Abstract

08:07

The potential of Macaca fuscata, as a recipient model for porcine islet xenotransplantation

Naoaki Sakata (JP)

Bio Abstract

08:14

Subcutaneous cell sheet transplantation as a superior strategy to intraportal route for induced pluripotent stem cell-derived pancreatic islet cells therapy

Koki Kurahashi (JP)

Bio Abstract

08:21

Engineering Pancreatic Islet Organoids with a Hierarchical Vascular Network

Jialin Cui (JP)

Bio Abstract

08:28

Development of a Pre-vascularized Subcutaneous Site Using a Clinically Available Bioabsorbable Device for Islet Transplantation

Norio Emoto (JP)

Bio Abstract

08:35

Generation of ISL1-Overexpressing Islets with Enhanced Resistance to Apoptosis and Ferroptosis Improves Transplantation Outcomes

Ying Wang (CN)

Bio Abstract

08:42

Immune cell and serum cytokine dynamics in islet transplant recipients receiving Belatacept/Sirolimus versus Tacrolimus/Mycophenolate

Rachel Cheong (AU)

Bio Abstract

08:47

PTBP1 promotes autophagy via the Slc22a17/Lcn2 axis to alleviate apoptosis in grafted islets

Jingwen Wang (CN)

Bio Abstract

08:52

Pharmacological Inhibition of mtROS-ARA-12-HETE Axis Enhances the Function and Therapeutic Potential of Stem Cell-Derived β Cells for Diabetes

Huanjing Bi (CN)

Bio Abstract